Source: The Business Journals: Boston

MPM: Cambridge oncology biotech closes another VC tranche, raising $122.5M

Less than two weeks ago, the Cambridge biotech also brought on a new CEO: the former U.S. CEO of Japanese pharma Eisai Inc.

Read full article »
MPM's Competitors | MPM's News | MPM's Financials
Stay up-to-date with the latest news on MPM
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Detlev Biniszkiewicz's photo - Managing Director of MPM

Managing Director

Detlev Biniszkiewicz

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on MPM